Laparoscopic retroperitoneal lymph node dissection in the management of testis cancer

Cancer Control

Volumn 14, Issue 3, 2007, Pages 258-264

  Correa, José J ^a   Politis, Christos ^a   Rodriguez, Alejandro R ^a   Pow Sang, Julio M ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE;

CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL PRACTICE; GERM CELL TUMOR; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; MULTIPLE CYCLE TREATMENT; NONSEMINOMATOUS GERM CELL TUMOR; PARAAORTIC LYMPH NODE; REVIEW; SURGICAL TECHNIQUE; TESTIS CANCER; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 34447301004     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480701400309     Document Type: Review

References (38)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Neyer M, Peschel R, Akkad T, et al. Long-term results of laparoscopic retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testicular cancer. J Endourol. 2007;21:180-183.
3. Rukstalis DB, Chodak GW. Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma. J Urol. 1992;148: 1907-1910.
4. Stone NN, Schlussel RN, Waterhouse RL, et al. Laparoscopic retroperitoneal lymph node dissection in stage A nonseminomatous testis cancer. Urology. 1993;42:610-614.
5. Castillo O, Wohler C, Mayanz M, et al. Laparoscopic lumboaortic retroperitoneal lymphadenectomy in testicular neoplasm. [Article in Spanish.] Rev Med Chil. 1994;122:313-318.
6. Gerber GS, Bissada NK, Hulbert JC, et al. Laparoscopic retroperitoneal lymphadenectomy: multi-institutional analysis. Gerber J Urol. 1994;152:1188-1192.
7. Janetschek G, Reissigl A, Peschel R, et al. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular tumor. Urology. 1994;44:382-391.
8. Levin HS. Prognostic features of primary and metastatic testis germcell tumors. Urol Clin North Am. 1993;20:39-53.
9. Ansfield FJ, Korbitz BC, Davis HL Jr, et al. Triple drug therapy in testicular tumors. Cancer. 1969;24:442-446.
10. Richie JP, Kantoff PW. Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer? J Clin Oncol. 1991;9:1393-1396.
11. Palese MA, Su LM, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection after chemotherapy. Urology. 2002;60:130-134.
12. Bales GT, Gerber GS, Rukstalis DB. Laparoscopic post-chemotherapy retroperitoneal dissection of residual mass. Br J Urol. 1997;80:349-350.
13. Albqami N, Janetschek G. Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer. J Endourol. 2005;19:683-692.
14. Albers P, Siener R, Kliesch S, et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol. 2003;21:1505-1512.
15. Amato RJ, Ro JY, Ayala AG, et al. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis. Urology. 2004;63:144-149.
16. Weissbach L, Boedefeld EA. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol. 1987;138:77-82.
17. Narayan P, Lange PH, Fraley EE. Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer. J Urol. 1982;127:685-688.
18. Donohue JP, Foster RS, Rowland RG, et al. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol. 1990;144(2 Pt 1):287-292.
19. Peschel R, Gettman MT, Neururer R, et al. Laparoscopic retroperitoneal lymph node dissection: description of the nerve-sparing technique. Urology. 2002;60:339-343.
20. Culine S, Droz JP. Primary treatment in stage II non-seminomatous germ cell tumours of the testis: a matter of scalpel or drug infusion? Eur J Cancer. 1996;32A:1641-1644.
21. LeBlanc E, Caty A, Dargent D, et al. Extraperitoneal laparoscopic para-aortic lymph node dissection for early stage nonseminomatous germ cell tumors of the testis with introduction of a nerve sparing technique: description and results . J Urol. 2001;165:89-92.
22. Weissbach L, Bussar-Maatz R, Flechtner H, et al. RPLND or primary chemotherapy in clinical stage IIA/B nonseminomatous germ cell tumors? Results of a prospective multicenter trial including quality of life assessment. Eur Urol. 2000;37:582-594.
23. Rabbani F, Sheinfeld J, Farivar-Mohseni H, et al. Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol. 2001;19:2020-2025.
24. Xiao H, Sheinfeld J, Motzer RJ. Adjuvant chemotherapy for testicular cancer. Surg Oncol Clin N Am. 1997;6:863-878.
25. Pohar KS, Rabbani F, Bosl GJ, et al. Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testis. J Urol. 2003;170(Pt 1):1155-1158.
26. Donohue JP. Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT). Urol Oncol. 2003;21:129-12.
27. Donohue JP, Rowland RG. The role of surgery in advanced testicular cancer. Cancer. 1984;54(11 suppl):2716-2721.
28. Permpongkosol S, Lima GC, Warlick CA, et al. Postchemotherapy laparoscopic retroperitoneal lymph node dissection: evaluation of complications. Urology. 2007;69:361-365.
29. Steiner H, Peschel R, Janetschek G, et al. Long-term results of laparoscopic retroperitoneal lymph node dissection: a single-center 10-year experience. Urology. 2004;63:550-555.
30. Janetschek G, Hobisch A, Holtl L, et al. Retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular tumor: laparoscopy versus open surgery and impact of learning curve. J Urol. 1996;156:89-94.
31. Janetschek G, Peschel R, Hobisch A, et al. Laparoscopic retroperitoneal lymph node dissection. J Endourol. 2001;15:449-455.
32. Donohue JP, Thornhill JA, Foster RS, et al. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. J Urol. 1993;149:237-243.
33. Eggener SE, Carver BS, Sharp DS, et al. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer. J Urol. 2007;177:937-943.
34. Holtl L, Peschel R, Knapp R, et al. Primary lymphatic metastatic spread in testicular cancer occurs ventral to the lumbar vessels. Urology. 2002;59:114-118.
35. Janetschek G. Laparoscopic lymph node dissection in urology. Curr Urol Rep. 2006;7:87-89.
36. Bhayani SB, Ong A, Oh WK, et al. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update. Urology. 2003;62:324-327.
37. Rassweiler JJ, Frede T, Lenz E, et al. Long-term experience with laparoscopic retroperitoneal lymph node dissection in the management of low-stage testis cancer. Eur Urol. 2000;37:251-260.
38. Rassweiler JJ, Seemann O, Henkel TO, et al. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations. J Urol. 1996;156:1108-1113.